Viewing StudyNCT00120536



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00120536
Status: COMPLETED
Last Update Posted: 2017-05-18
First Post: 2005-07-12

Brief Title: Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
vildagliptin View
Type 2 diabetes View